BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15036568)

  • 1. Sustained perimacular vascular and visual response to topical beta blockers in normal human eyes.
    Sponsel WE
    Brain Res Bull; 2004 Feb; 62(6):529-35. PubMed ID: 15036568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lack of efficacy of topical beta-blockers, timolol and betaxolol on intraocular pressure in Nigerian healthy volunteers.
    Olateju SO; Ajayi AA
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():758-63. PubMed ID: 10707140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of nimodipine, a centrally active calcium antagonist, on visual function and mascular blood flow in patients with normal-tension glaucoma and control subjects.
    Piltz JR; Bose S; Lanchoney D
    J Glaucoma; 1998 Oct; 7(5):336-42. PubMed ID: 9786563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.
    Krupin T; Liebmann JM; Greenfield DS; Rosenberg LF; Ritch R; Yang JW;
    Ophthalmology; 2005 Mar; 112(3):376-85. PubMed ID: 15745762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of the effectiveness of beta-blockers for intraocular pressure and visual field in primary open-angle glaucoma].
    Dobre X
    Oftalmologia; 2008; 52(4):95-9. PubMed ID: 19354170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta1-adrenergic receptor polymorphisms and clinical efficacy of betaxolol hydrochloride in normal volunteers.
    Schwartz SG; Puckett BJ; Allen RC; Castillo IG; Leffler CT
    Ophthalmology; 2005 Dec; 112(12):2131-6. PubMed ID: 16325708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A placebo-controlled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure.
    Koseki N; Araie M; Tomidokoro A; Nagahara M; Hasegawa T; Tamaki Y; Yamamoto S
    Ophthalmology; 2008 Nov; 115(11):2049-57. PubMed ID: 18672290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual field and intraocular pressure asymmetry in the low-pressure glaucoma treatment study.
    Greenfield DS; Liebmann JM; Ritch R; Krupin T;
    Ophthalmology; 2007 Mar; 114(3):460-5. PubMed ID: 17141318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual field changes after transient elevation of intraocular pressure in eyes with and without glaucoma.
    Chan KC; Poostchi A; Wong T; Insull EA; Sachdev N; Wells AP
    Ophthalmology; 2008 Apr; 115(4):667-72. PubMed ID: 17716733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma.
    Quaranta L; Gandolfo F; Turano R; Rovida F; Pizzolante T; Musig A; Gandolfo E
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2917-23. PubMed ID: 16799034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of intraocular pressure reduction on perimetric variability in glaucomatous eyes.
    Fogagnolo P; McNaught A; Centofanti M; Rossetti L; Orzalesi N
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4557-63. PubMed ID: 17898278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Effect of Topical (beta-Adrenergic Antagonists on Normal Perimacular Hemodynamics.
    Harris A; Shoemaker JA; Burgoyne J; Weinland M; Cantor LB
    J Glaucoma; 1995 Feb; 4(1):36-40. PubMed ID: 19920635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of spatial contrast sensitivity threshold after surgical reduction of intraocular pressure in unilateral high-tension glaucoma.
    Gandolfi SA; Cimino L; Sangermani C; Ungaro N; Mora P; Tardini MG
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):197-201. PubMed ID: 15623774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical dorzolamide increases pericentral visual function in age-related maculopathy: pilot study findings with short-wavelength automated perimetry.
    Remky A; Weber A; Arend O; Sponsel WE
    Acta Ophthalmol Scand; 2005 Apr; 83(2):154-60. PubMed ID: 15799725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optic disc and visual field changes after trabeculectomy.
    Kotecha A; Spratt A; Bunce C; Garway-Heath DF; Khaw PT; Viswanathan A;
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4693-9. PubMed ID: 19474409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraocular pressure elevation within the first 24 hours after cataract surgery in patients with glaucoma or exfoliation syndrome.
    Levkovitch-Verbin H; Habot-Wilner Z; Burla N; Melamed S; Goldenfeld M; Bar-Sela SM; Sachs D
    Ophthalmology; 2008 Jan; 115(1):104-8. PubMed ID: 17561259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraocular pressure-lowering efficacy of brinzolamide 1%/timolol 0.5% fixed combination compared with brinzolamide 1% and timolol 0.5%.
    Kaback M; Scoper SV; Arzeno G; James JE; Hua SY; Salem C; Dickerson JE; Landry TA; Bergamini MV;
    Ophthalmology; 2008 Oct; 115(10):1728-34, 1734.e1-2. PubMed ID: 18538406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal capillary hemodynamics, visual-evoked potentials, and pressure tolerance in normal human eyes.
    Zetlan SR; Sponsel WE; Stodtmeister R
    Invest Ophthalmol Vis Sci; 1992 May; 33(6):1857-63. PubMed ID: 1582789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.